-
Tanzania president wins election landslide after deadly protests
-
Sixers suffer first loss, Bulls stay perfect as NBA Cup opens
-
Dodgers, Blue Jays gear up for winner-take-all World Series game seven
-
Taiwan's new opposition leader against defence spending hike
-
China to exempt some Nexperia chips from export ban
-
Dodgers hold off Blue Jays 3-1 to force World Series game seven
-
Crowns, beauty, fried chicken: Korean culture meets diplomacy at APEC
-
Panama wins canal expansion arbitration against Spanish company
-
Myanmar fireworks festival goers shun politics for tradition
-
China to exempt some Nexperia orders from export ban
-
Sixers suffer first loss as NBA Cup begins
-
China's Xi to meet South Korean leader, capping APEC summit
-
Japan's Chiba leads after Skate Canada short program
-
Finland's crackdown on undocumented migrants sparks fear
-
Climbers test limits at Yosemite, short-staffed by US shutdown
-
Gstaad gives O'Brien record 21st Breeders' Cup win
-
After the tears, anger on Rio's blood-stained streets
-
Sinner boosts number one bid in Paris, to face Zverev in semis
-
Springer back in Toronto lineup as Blue Jays try to close out Dodgers
-
Nationals make Butera MLB's youngest manager since 1972
-
Guirassy lifts Dortmund past Augsburg ahead of Man City clash
-
G7 says it's 'serious' about confronting China's critical mineral dominance
-
NFL fines Ravens $100,000 over Jackson injury status report
-
NBA refs to start using headsets on Saturday
-
Trump says Christians in Nigeria face 'existential threat'
-
French-Turkish actor Tcheky Karyo dies at 72
-
Food stamps, the bulwark against hunger for over 40 mn Americans
-
Trump keeps world guessing with shock nuclear test order
-
Wall Street stocks rebound on Amazon, Apple earnings
-
US Fed official backed rate pause because inflation 'too high'
-
Prayers and anthems: welcome to the Trump-era Kennedy Center
-
Swiss central bank profits boosted by gold price surge
-
Sinner beats Shelton to boost number one bid in Paris
-
French court jails Bulgarians for up to four years for Holocaust memorial defacement
-
Profits dip at ExxonMobil, Chevron on lower crude prices
-
Ashraf and Mirza skittle South Africa as Pakistan win 2nd T20
-
2,000 trucks stuck in Belarus after Lithuania closes border: association
-
French lawmakers reject wealth tax proposal in budget debate
-
Premier League blames European expansion for lack of Boxing Day games
-
Bublik sets up Auger-Aliassime semi-final at Paris Masters
-
World's most expensive coffee goes on sale in Dubai at $1,000 a cup
-
Trump stirs global tensions, confusion with nuclear test order
-
Panic across US as health insurance costs set to surge
-
Court eases ban on Russian lugers but Olympic hopes on thin ice
-
England captain Itoje targets Autumn Nations clean sweep
-
Calmer Sabalenka sets sights on WTA Finals crown
-
Spurs boosted by Romero return for Chelsea clash
-
Sudan's RSF claims arrests as UN warns of 'horrendous' atrocities in Darfur
-
US says 'non-market' tactics needed to counter China's rare earth dominance
-
China sends youngest astronaut, mice to space station
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
C.Hamad--SF-PST